Integra LifeSciences Holdings (IART) — Cash Flow-to-Debt Ratio
Integra LifeSciences Holdings (IART) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of $9.80 Million could theoretically repay 0% of its total liabilities ($2.54 Billion) in one year. See Integra LifeSciences Holdings financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Integra LifeSciences Holdings Cash Flow-to-Debt Ratio (1995–2025)
Historical debt coverage capacity for Integra LifeSciences Holdings across 31 annual periods. For the full cash flow conversion analysis, see IART cash flow metrics.
Annual Cash Flow-to-Debt Ratio for Integra LifeSciences Holdings (1995–2025)
Year-by-year debt coverage analysis for Integra LifeSciences Holdings. Check IART cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.02x | $50.38 Million | $2.56 Billion | ▼ -62.1% |
| 2024 | 0.05x | $129.38 Million | $2.49 Billion | ▼ -18.6% |
| 2023 | 0.06x | $139.96 Million | $2.19 Billion | ▼ -49.7% |
| 2022 | 0.13x | $264.47 Million | $2.09 Billion | ▼ -14.9% |
| 2021 | 0.15x | $312.43 Million | $2.10 Billion | ▲ +53.5% |
| 2020 | 0.10x | $203.83 Million | $2.10 Billion | ▼ -20.9% |
| 2019 | 0.12x | $231.43 Million | $1.89 Billion | ▲ +6.4% |
| 2018 | 0.12x | $199.68 Million | $1.73 Billion | ▲ +126.3% |
| 2017 | 0.05x | $114.54 Million | $2.25 Billion | ▼ -57.6% |
| 2016 | 0.12x | $116.41 Million | $968.29 Million | ▲ +30.2% |
| 2015 | 0.09x | $94.48 Million | $1.02 Billion | ▲ +1.6% |
| 2014 | 0.09x | $79.46 Million | $874.30 Million | ▼ -10.2% |
| 2013 | 0.10x | $53.27 Million | $526.05 Million | ▲ +11.4% |
| 2012 | 0.09x | $58.72 Million | $645.82 Million | ▼ -43.2% |
| 2011 | 0.16x | $104.33 Million | $651.47 Million | ▼ -21.5% |
| 2010 | 0.20x | $105.57 Million | $517.35 Million | ▼ -29.4% |
| 2009 | 0.29x | $143.24 Million | $495.22 Million | ▲ +172.6% |
| 2008 | 0.11x | $72.59 Million | $684.23 Million | ▲ +25.8% |
| 2007 | 0.08x | $47.03 Million | $557.58 Million | ▼ -62.7% |
| 2006 | 0.23x | $71.70 Million | $317.46 Million | ▼ -37.0% |
| 2005 | 0.36x | $56.85 Million | $158.61 Million | ▲ +36.9% |
| 2004 | 0.26x | $38.98 Million | $148.89 Million | ▲ +8.2% |
| 2003 | 0.24x | $34.83 Million | $144.00 Million | ▼ -79.5% |
| 2002 | 1.18x | $31.98 Million | $27.07 Million | ▲ +77.1% |
| 2001 | 0.67x | $15.70 Million | $23.53 Million | ▲ +540.3% |
| 2000 | -0.15x | $-4.96 Million | $32.73 Million | ▼ -271.5% |
| 1999 | 0.09x | $2.50 Million | $28.30 Million | ▲ +103.0% |
| 1998 | -2.97x | $-9.80 Million | $3.30 Million | ▲ +2.3% |
| 1997 | -3.04x | $-7.90 Million | $2.60 Million | ▲ +12.6% |
| 1996 | -3.48x | $-8.00 Million | $2.30 Million | ▼ -24.2% |
| 1995 | -2.80x | $-5.60 Million | $2.00 Million | — |